Literature DB >> 11025724

Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms.

I Araki1, M Kitahara, T Oida, S Kuno.   

Abstract

PURPOSE: We evaluated bladder dysfunction and Parkinson's disease in regard to disease severity and determined whether subjective patient urinary symptoms correlated with urodynamic abnormalities.
MATERIALS AND METHODS: We assessed bladder dysfunction in 70 patients with Parkinson's disease and urinary symptoms using the International Prostate Symptom Score and urodynamic tests.
RESULTS: Urodynamic evaluation revealed detrusor hyperreflexia in 47 patients (67%), hyporeflexia or areflexia in 11 (16%), hyperreflexia with impaired contractile function in 6 (9%), hyperreflexia with detrusor-sphincter dyssynergia in 2 (3%) and normal function in 4 (6%). The incidence of urodynamic abnormalities appeared to increase with disease severity. However, the only urodynamic parameter that correlated with disease severity was post-void residual urine volume. On the other hand, symptom index scores increased with disease severity. The irritative symptom score correlated with maximum cystometric capacity and volume at initial desire to void, whereas the obstructive symptom score correlated with post-void residual urine volume. Also, irritative and obstructive scores were good predictors of overactivity during the storage and underactivity at the voiding phases.
CONCLUSIONS: Bladder function may deteriorate progressively with advancing disease. Symptom scores are fairly accurate for predicting likely urodynamic abnormalities. Our results imply that quantifying subjective urinary symptoms is useful for estimating the severity and type of bladder dysfunction.

Entities:  

Mesh:

Year:  2000        PMID: 11025724

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  41 in total

1.  Neurogenic Causes of Detrusor Underactivity.

Authors:  Brian T Kadow; Pradeep Tyagi; Christopher J Chermansky
Journal:  Curr Bladder Dysfunct Rep       Date:  2015-09-15

2.  Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder.

Authors:  Carolina Gil-Tommee; Guadalupe Vidal-Martinez; C Annette Reyes; Javier Vargas-Medrano; Gloria V Herrera; Silver M Martin; Stephanie A Chaparro; Ruth G Perez
Journal:  Exp Neurol       Date:  2018-10-25       Impact factor: 5.330

Review 3.  Integrated control of lower urinary tract--clinical perspective.

Authors:  Clare J Fowler
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

4.  Dopamine is produced in the rat spinal cord and regulates micturition reflex after spinal cord injury.

Authors:  Shaoping Hou; David M Carson; Di Wu; Michelle C Klaw; John D Houlé; Veronica J Tom
Journal:  Exp Neurol       Date:  2015-12-02       Impact factor: 5.330

5.  Brain switch for reflex micturition control detected by FMRI in rats.

Authors:  Changfeng Tai; Jicheng Wang; Tao Jin; Ping Wang; Seong-Gi Kim; James R Roppolo; William C de Groat
Journal:  J Neurophysiol       Date:  2009-09-09       Impact factor: 2.714

6.  The other bladder syndrome: underactive bladder.

Authors:  Minoru Miyazato; Naoki Yoshimura; Michael B Chancellor
Journal:  Rev Urol       Date:  2013

7.  Bladder dysfunction in presymptomatic gene carriers and patients with Huntington's disease.

Authors:  Matej Kolenc; Metka Moharić; Jan Kobal; Simon Podnar
Journal:  J Neurol       Date:  2014-09-20       Impact factor: 4.849

Review 8.  Neural control of the lower urinary tract.

Authors:  William C de Groat; Derek Griffiths; Naoki Yoshimura
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

9.  Association between cognitive impairment and urinary dysfunction in Parkinson's disease.

Authors:  Zuzanna Tkaczynska; Andrea Pilotto; Sara Becker; Susanne Gräber-Sultan; Daniela Berg; Inga Liepelt-Scarfone
Journal:  J Neural Transm (Vienna)       Date:  2017-02-17       Impact factor: 3.575

10.  FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces α-Synuclein Pathology in Parkinsonian GM2+/- Mice.

Authors:  Guadalupe Vidal-Martinez; Katherine Najera; Julie D Miranda; Carolina Gil-Tommee; Barbara Yang; Javier Vargas-Medrano; Valeria Diaz-Pacheco; Ruth G Perez
Journal:  Neuroscience       Date:  2019-05-23       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.